Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.

Expert opinion on pharmacotherapy - 1 Sept 2005

Nikpoor Borzoo, Duan Qing Ling, Rouleau Guy A

Abstract excerpt

Angiotensin-converting enzyme inhibitors (ACEIs) have been used in the treatment of various cardiovascular diseases. Despite the therapeutic benefits of ACEIs, there are several reported side effects, including chronic cough, angioedema and anaphylactoid reactions. These adverse events cannot be explained by the vasodilatory effects of this group of medications. Preliminary studies have shown that patients with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminopeptidases
Share to Anaphylaxis
Share to Angioedema

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Angiotensin-Converting Enzyme Inhibitors

Share to Bradykinin

Share to Peptidyl-Dipeptidase A

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 16144506
DOI: 10.1517/14656566.6.11.1851

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications.PMID 16144506Read ↗

Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches.Semantic proximity Read ↗

Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough.Semantic proximity Read ↗

[Physiopathology of the acute adverse effects of angiotensin-converting-enzyme inhibitors].Semantic proximity Read ↗

Angiotensin-converting enzyme inhibitor-associated angioedema.Semantic proximity Read ↗

Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?Semantic proximity Read ↗

Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors.Semantic proximity Read ↗

Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery.Semantic proximity Read ↗

Angiotensin I converting enzyme gene: regulation, polymorphism and implications in cardiovascular diseases.Semantic proximity Read ↗

Angiotensin I-converting enzyme: genotype and disease associations.Semantic proximity Read ↗

The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.Semantic proximity Read ↗

Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes.Semantic proximity Read ↗

Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.